The role of p73 in hematological malignancies (Q36422865)

14 August 2017

1 reference

title

The role of p73 in hematological malignancies (English)

1 reference

14 August 2017

B Zhivotovsky

0 references

T Robak

1 reference

14 August 2017

A Pluta

1 reference

14 August 2017

U Nyman

series ordinal

1 reference

14 August 2017

B Joseph

series ordinal

1 reference

14 August 2017

P Smolewski

series ordinal

1 reference

14 August 2017

publication date

1 May 2006

1 reference

14 August 2017

1 reference

14 August 2017

1 reference

14 August 2017

1 reference

14 August 2017

page(s)

757-766

1 reference

Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

TP53 family members and human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

p53 alterations in myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

TP53 in hematological cancer: low incidence of mutations with significant clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

p53 protein variants: structural and functional similarities with p63 and p73 isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

The C terminus of p53 family proteins is a cell fate determinant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

p53 isoforms can regulate p53 transcriptional activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

A novel human p53 isoform is an essential element of the ATR-intra-S phase checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Differential expression of p63 isoforms in normal tissues and neoplastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

The promyelocytic leukaemia protein tumour suppressor functions as a transcriptional regulator of p63.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

The transactivating isoforms of p63 are overexpressed in high-grade follicular lymphomas independent of the occurrence of p63 gene amplification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Expression of p63 in diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Functional regulation of p73 and p63: development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Mutation analysis of the p73 gene in nonastrocytic brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Detection of p73 antibodies in patients with various types of cancer: immunological characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Analysis of p73 in human borderline and invasive ovarian tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Expression of deltaNp73 predicts poor prognosis in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

p73: Friend or foe in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Role of p73 in malignancy: tumor suppressor or oncogene?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Quantitative TP73 transcript analysis in hepatocellular carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Two new p73 splice variants, gamma and delta, with different transcriptional activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Transactivation-dependent and -independent regulation of p73 stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Role for the p53 homologue p73 in E2F-1-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

A common E2F-1 and p73 pathway mediates cell death induced by TCR activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

p73 induces apoptosis by different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

E1A activates transcription of p73 and Noxa to induce apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

The p53 family: same response, different signals?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

p73 is a simian [correction of human] p53-related protein that can induce apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Alteration of p73 in pediatric de novo acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Concurrent methylation of multiple genes in childhood ALL: Correlation with phenotype and molecular subgroup.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Childhood and adult ALL: differences in epigenetic lesions associated with cell cycle genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Overexpression of the p73 gene is a novel finding in high-risk B-cell chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

RETRACTED: Alteration of p73 in acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Methylation profiling in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

CpG island methylation of tumor-related genes in three primary central nervous system lymphomas in immunocompetent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

DNA-methylation analysis identifies the E-cadherin gene as a potential marker of disease progression in patients with monoclonal gammopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

5-Aza-2'-deoxycytidine induces p21WAF expression by demethylation of p73 leading to p53-independent apoptosis in myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Methylation status analysis of cell cycle regulatory genes (p16INK4A, p15INK4B, p21Waf1/Cip1, p27Kip1 and p73) in natural killer cell disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Efficient growth inhibition of HPV 16 E6-expressing cells by an adenovirus-expressing p53 homologue p73beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Regulation of the p53 homolog p73 by adenoviral oncogene E1A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

p73 beta-expressing recombinant adenovirus: a potential anticancer agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Stable suppression of tumorigenicity by virus-mediated RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

DeltaNp73 antisense activates PUMA and induces apoptosis in neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Synthetic small inhibiting RNAs: efficient tools to inactivate oncogenic mutations and restore p53 pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Rescue of mutant p53 transcription function by ellipticine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Treatment with arsenic trioxide (ATO) and MEK1 inhibitor activates the p73-p53AIP1 apoptotic pathway in leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Change of Conformation of the DNA-binding Domain of p53 Is the Only Key Element for Binding of and Interference with p73

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Polymorphisms ofp53Arg72Pro,p73G4C14-to-A4T14 at Exon 2 andp21Ser31Arg and the risk of non-Hodgkin's Lymphoma in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

Additional complexity in p73: induction by mitogens in lymphoid cells and identification of two new splicing variants ε and ζ

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

The continuing saga of p53--more sleepless nights ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

1 reference

7 January 2021

p73 is up-regulated in a subset of hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

7 January 2021

Wild type p73 overexpression and high-grade malignancy in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

7 January 2021

New p73 variants with altered C-terminal structures have varied transcriptional activities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

7 January 2021

Lack of p73 expression in mature B-ALL and identification of three new splicing variants restricted to pre B and C-ALL indicate a role of p73 in B cell ALL differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

7 January 2021

p73 function is inhibited by tumor-derived p53 mutants in mammalian cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

7 January 2021

P73 status in B-cell chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

7 January 2021

Aberrant methylation of multiple tumor suppressor genes in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

7 January 2021

Enhanced p73 expression during differentiation and complex p73 isoforms in myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

7 January 2021

Analysis of p73 expression pattern in acute myeloid leukemias: lack of DeltaN-p73 expression is a frequent feature of acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

7 January 2021

The p73 locus is commonly deleted in non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

7 January 2021

Specific patterns of gene methylation in natural killer cell lymphomas : p73 is consistently involved

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

7 January 2021

DNA methylation changes in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

7 January 2021

Aberrant gene promoter methylation in acute promyelocytic leukaemia: profile and prognostic significance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

7 January 2021

Loss of p73 gene expression in lymphoid leukemia cell lines is associated with hypermethylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

7 January 2021

Protein expression of a triad of frequently methylated genes, p73, p57Kip2, and p15, has prognostic value in adult acute lymphocytic leukemia independently of its methylation status

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

7 January 2021

Allelic losses and genetic instabilities of PTEN and p73 in non-Hodgkin lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

7 January 2021

Frequent inactivation of thep73gene by abnormal methylation or LOH in non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

7 January 2021

Analysis of p73 and p53 gene deletions in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404166

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2404166

1 reference

14 August 2017

1 reference